3647 results for «629»

Filter By

3647 results

Opening ceremony

08 Apr 2017 – From PCR Tokyo Valves 2017

Closing Ceremony and Awards

09 Apr 2017 – From PCR Tokyo Valves 2017

GulfPCR-GIM 2017 Opening Ceremony

13 Dec 2017 – From GulfPCR-GIM 2017

Consult the Opening ceremony of GulfPCR-GIM 2017 by W. Wijns if you want to find out more about the components of the SYNTAX II strategy and the best of PCI practice. Prevention and management of diabetes plays an important role in improving patient care in the...

GulfPCR-GIM 2017 Opening Ceremony

GulfPCR-GIM 2017 Award and Closing Ceremony

14 Dec 2017 – From GulfPCR-GIM 2017

Consult the Award and closing ceremony for GulfPCR-GIM 2017, if you find out who this year's Best Clinical Case winner is.

GulfPCR-GIM 2017: Award and Closing Ceremony

DK crush technique in a calcified LAD-diagonal bifurcation - LIVE case

20 May 2026 – From EuroPCR 2026

A 53‑year‑old man with hypertension and dyslipidemia presented with an inferior MI treated with primary PCI of the RCA two months earlier. He was referred for staged treatment of a significant calcified LAD–diagonal bifurcation lesion. Lesion preparation included non‑compliant balloon dilatation, rotational atherectomy in the LAD...

DK crush technique in a calcified LAD-diagonal bifurcation - LIVE case

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)

31 Mar 2025

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Nicola Ryan

Author

Nicola Ryan
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease

Everolimus-eluting stents or bypass surgery for mutivessel coronary artery disease: 10-year outcomes of multicenter randomized controlled BEST trial

20 Sep 2022

Nicola Ryan provides her take on the BEST trial which was presented by Jung-Min Ahn at TCT 2022.

It is a randomised, multicentre, non-inferiority trial comparing PCI with second-generation everolimus-eluting stents and CABG in patients with non-left main multivessel coronary artery disease. At two-year follow-up PCI was shown...

Nicola Ryan

Author

Nicola Ryan
10-Year Outcomes of Multicenter Randomized Controlled BEST Trial: Everolimus-Eluting Stents or Bypass Surgery for Mutivessel CAD
Didn’t find what you were looking for?